Fuller L, Fernandez J, Zheng S, Carreno M, Esquenazi V, Yang W C, Miller J
Department of Surgery, University of Miami School of Medicine, Florida.
Transplantation. 1992 Jan;53(1):195-202.
We have advanced the hypothesis that the primary autolymphoproliferative response of dog T cells in mixed lymphocyte kidney cultures (MLKC) results from their recognition of tissue-specific (kidney-associated) antigen(s) presented in conjunction with class II MHC antigens. Lymphocyte culture-derived supernatants had been found previously to upregulate class II antigen expression on kidney cells and enhance T cell activation. In the present study we have isolated and characterized dog IFN-gamma, a class II-inducing substance that is secreted in the culture supernatant of activated T lymphocytes. Dog IFN-gamma was induced with A-23187 and PMA and purified stepwise using controlled-pore glass, Mono Q anion exchange chromatography, and Superose 6-gel filtration on FPLC. The purification resulted in two molecules of 42 Kd and 31 Kd molecular weights. An IgG1 monoclonal antibody was engendered to these molecules. With this mAb reagent, in immunochemical experiments, we have developed a sensitive ELISA and a method for purifying dog IFN-gamma by affinity chromatography. Species specificity studies indicated that purified dog IFN-gamma reacted with a polyclonal rabbit antihuman IFN-gamma, but not with a mAb to human IFN-gamma. However, the antidog IFN-gamma mAb that was generated also reacted with recombinant human IFN-gamma. In in vitro biological studies, the purified IFN-gamma (two mol. wt. species) upregulated the expression of canine class II MHC molecules on dog tubular epithelial cells and the dog kidney epithelial cell line (MDCK). The antidog IFN-gamma mAb blocked T cell proliferative response to kidney cell and, by inference, the interaction between endogenously released IFN-gamma in vitro with its cell surface receptor, thus inhibiting the induced upregulation of class II. Interestingly, although antidog IFN-gamma markedly blocked the MLKC (10 micrograms mAb/well), there was no effect on the allogeneic MLC. This observation indicates that the cytokine IFN-gamma may be a uniquely key substance amplifying the immune response of T cells to tissue-associated antigens on surrogate antigen-presenting cells that require induced upregulation of class II MHC antigen expression (MLKC), in contrast to reactions in which these antigens are already constitutively expressed on the antigen-presenting cells (mixed lymphocyte culture).
我们提出了一个假说,即犬T细胞在混合淋巴细胞肾脏培养物(MLKC)中的主要自身淋巴细胞增殖反应是由于它们识别了与II类MHC抗原结合呈递的组织特异性(肾脏相关)抗原。先前已发现淋巴细胞培养物来源的上清液可上调肾脏细胞上的II类抗原表达并增强T细胞活化。在本研究中,我们分离并鉴定了犬干扰素-γ,一种在活化T淋巴细胞培养上清液中分泌的II类诱导物质。犬干扰素-γ用A-23187和佛波酯诱导产生,并在FPLC上使用控孔玻璃、Mono Q阴离子交换色谱和Superose 6凝胶过滤进行逐步纯化。纯化得到了分子量分别为42 Kd和31 Kd的两种分子。针对这些分子产生了一种IgG1单克隆抗体。利用这种单克隆抗体制剂,在免疫化学实验中,我们开发了一种灵敏的ELISA方法以及一种通过亲和色谱纯化犬干扰素-γ的方法。种属特异性研究表明,纯化的犬干扰素-γ与兔抗人干扰素-γ多克隆抗体反应,但不与抗人干扰素-γ单克隆抗体反应。然而,所产生的抗犬干扰素-γ单克隆抗体也与重组人干扰素-γ反应。在体外生物学研究中,纯化的干扰素-γ(两种分子量形式)上调了犬肾小管上皮细胞和犬肾上皮细胞系(MDCK)上犬II类MHC分子的表达。抗犬干扰素-γ单克隆抗体阻断了T细胞对肾细胞的增殖反应,由此推断,阻断了体外内源性释放的干扰素-γ与其细胞表面受体之间的相互作用,从而抑制了诱导的II类上调。有趣的是,尽管抗犬干扰素-γ显著阻断了MLKC(每孔10微克单克隆抗体),但对同种异体混合淋巴细胞培养(MLC)没有影响。这一观察结果表明,细胞因子干扰素-γ可能是一种独特的关键物质,可放大T细胞对替代抗原呈递细胞上组织相关抗原的免疫反应(MLKC),在这种反应中需要诱导上调II类MHC抗原表达,这与抗原呈递细胞上这些抗原已组成性表达的反应(混合淋巴细胞培养)形成对比。